HSF5 and Alzheimer disease: Prior computational studies have highlighted the centrality of specific TFs, such as STAT1 and HSF5, in controlling glycosyltransferase gene expression in the AD brain (Tang et al., 2023), and these regulatory axes are predicted to alter glycan biosynthesis in a cell-type and region-specific manner.